Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OLEMA PHARMACEUTICALS, INC.

(OLMA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Slump With Market Tuesday

11/30/2021 | 04:05pm EST


ę MT Newswires 2021
All news about OLEMA PHARMACEUTICALS, INC.
01/04Olema Oncology to Present at 40th AnnualáJ.P. Morgan Healthcare Conference
GL
01/04Olema Oncology to Present at 40th AnnualáJ.P. Morgan Healthcare Conference
GL
2021OLEMA PHARMACEUTICALS, INC.(NASDAQGS : OLMA) added to NASDAQ Biotechnology Index
CI
2021Health Care Stocks Slump With Market Tuesday
MT
2021Olema Oncology Announces First Clinical Data on OP-1250 ináAdvanced ER+ / HER2- Breast ..
AQ
2021Olema Pharmaceuticals, Inc. Announces First Clinical Data on OP-1250 in?Advanced ER+ / ..
CI
2021Olema Warns About Fake Information About Drug Candidate Being Circulated on Internet
MT
2021Olema Oncology Issues Statement Regarding Falsified Information Circulating on Social M..
GL
2021Olema Oncology Issues Statement Regarding Falsified Information Circulating on Social M..
GL
2021Olema Oncology to Present New Data on OP-1250 at 2021 San Antonio Breast Cancer Symposi..
GL
More news
Analyst Recommendations on OLEMA PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -70,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,75x
Yield 2021 -
Capitalization 261 M 261 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 61
Free-Float -
Chart OLEMA PHARMACEUTICALS, INC.
Duration : Period :
Olema Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OLEMA PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 6,56 $
Average target price 46,25 $
Spread / Average Target 605%
EPS Revisions
Managers and Directors
Sean Bohen President, Chief Executive Officer & Director
Shane William Charles Kovacs Chief Operating & Financial Officer
Ian T. Clark Chairman
Pamela M. Klein Chief Medical Officer
Peter J. Kushner Director
Sector and Competitors
1st jan.Capi. (M$)
OLEMA PHARMACEUTICALS, INC.-29.91%261
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%53 950
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684